Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

NuRx, QuantRx deal

February 8, 2010 8:00 AM UTC

QuantRx will acquire partner NuRx in a stock deal valued at $15.2 million based on QuantRx's close of $0.42, on Jan. 28, the day before the deal was announced. NuRx shareholders will receive 1.5 QuantRx shares for every NuRx share held, or about 36.2 million QuantRx shares.

The companies have QN Diagnostics LLC, a 50/50 JV formed in July to develop and commercialize point-of-care diagnostics. QuantRx gains full ownership of the JV. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article